In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes how a molecule called HLA-DRB1 can be used as a target for chimeric antigen ...

If iPS cell lines could be derived from donors' somatic cells with an efficiency and safety profile that was comparable to ES cell lines, an opportunity exists to establish more efficient HLA ...

Determining the specificity of HLA antibodies is arguably one of the most important contributions by the HLA laboratory today. For patients that have low-to-moderate levels of antibody ...